| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
| 8,125 |
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
| 8,125 |
-
| | | Operating Expenses | | Research Development | (241) | (85) | 9,893 | 12,855 | | Selling General and Administrative | 991 | 2,124 | 2,487 | 2,936 | | Non Recurring |
-
|
-
|
-
| 2,810 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (750) | (2,039) | (4,255) | (18,601) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52 |
-
| 12 | 1,478 | | Earnings Before Interest And Taxes | (698) | (2,039) | (4,243) | (17,123) | | Interest Expense |
-
| 4 | 9 | 25 | | Income Before Tax | (698) | (2,043) | (4,252) | (17,148) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (698) | (2,043) | (4,252) | (17,148) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (698) | (2,043) | (4,252) | (17,148) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($698) | ($2,043) | ($4,252) | ($17,148) |
|
0.31% Nasdaq 
0.05%
Income Statement
